MOLECULAR MECHANISMS REGULATING BIOLOGICAL HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKEMIA: FROM THE VARIABLE SIGNALING RESPONSE TO CD20 ANTIBODIES AND KINASE INHIBITORS TO THE DIFFERENTIAL EXPRESSION OF CATALASE